
Experience
Definitive Healthcare Acquires Populi
August 14, 2023
Cooley advised Definitive Healthcare, a commercial intelligence company focused on healthcare, on its acquisition of Populi.
Related contacts
Related Practices & Industries
Travere Sells Bile Acid Product Portfolio to Mirum
July 18, 2023
Cooley advised Travere Therapeutics, a biopharmaceutical company, on its definitive agreement to sell its bile acid product portfolio to Mirum Pharmaceuticals.
Related contacts
Related Practices & Industries
Apollo Endosurgery to Be Acquired by Boston Scientific
February 1, 2023
Cooley advised Apollo Endosurgery, a medical device company, on its agreement to be acquired by Boston Scientific in an all-cash transaction with an enterprise value of approximately $615 million.
Related contacts
CinCor Pharma to Sell to AstraZeneca for Approximately $1.8 Billion
January 10, 2023
Cooley advised CinCor Pharma, a clinical-stage biopharmaceutical company, on its definitive agreement to be acquired by AstraZeneca. M&A partners Rama Padmanabhan and Rowook Park and corporate partners Div Gupta and Sarah Sellers led the Cooley team.
Related contacts
Related Practices & Industries
Biote Agrees to Combine With SPAC Haymaker Acquisition Corp. III
December 16, 2021
Cooley advised Biote, a medical practice-building business within the hormone optimization space, on its definitive business combination agreement with special purpose acquisition company (SPAC) Haymaker Acquisition Corp III. Lawyers Michal Berkner and Jarrett Burks led the Cooley team advising Biote.